Roivant Sciences is a biopharmaceutical company focused on rapidly delivering innovative solutions to improve health. With a strong following of over 20,000 followers on LinkedIn, Roivant Sciences is dedicated to reinventing the biopharma industry. Recently, the company has attracted significant interest for its bowel drug, with reports suggesting a potential valuation of over $7 billion.

$ROIV Roivant Sciences (ROIV) Said To Attract Interest For $7 Billion-plus Bowel Drug - Bloomberg. Last editedOpens edit history 6:35 PM ...

Roivant Sciences | 20758 followers on LinkedIn. Reinventing Biopharma | Roivant aims to improve health by rapidly delivering innovative ...

Roivant Sciences ROIV

Find contacts at this company